Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF — Mauro Gori (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF
Shared by
Aldo Maggioni
Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF
Article
2021
en
Authors
+16 more
MG
Mauro Gori
MS
Michele Senni
BC
Brian Claggett
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2025
High-Sensitivity Cardiac Troponin T Elevation and Paroxysmal Supraventricular Tachycardia. Is it Always Acute Coronary Syndrome?
Serena Miccichè
,
Giuseppe Pelaggi
,
Maria Claudia Lo Nigro
,
Sagui Celeste
,
Alice Moncada
,
Olga La Cognata
,
Armando Lo Savio
,
Salvatore Bonanno
,
Paolo Bellocchi
,
Giancarlo Agnelli
,
Alessio Currò
Letter
2020
Heart failure features and sacubitril/valsartan effects
Gabriella Malfatto
,
Alessandra Villani
,
Gianfranco Parati
Article
2020
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration?
Alessandra Villani
,
Silvia Ravaro
,
Paolo Cerea
,
Sergio Caravita
,
Francesca Ciambellotti
,
Giovanna Branzi
,
Carlotta Munforti
,
Gianfranco Parati
,
Gabriella Malfatto
Dataset
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration?
Alessandra Villani
,
Silvia Ravaro
,
Paolo Cerea
,
Sergio Caravita
,
Francesca Ciambellotti
,
Giovanna Branzi
,
Carlotta Munforti
,
Gianfranco Parati
,
Gabriella Malfatto
Article
2020
Treatment with sacubitril/valsartan in European outpatients with chronic heart failure in Europe: results from ARIADNE registry
Aldo Maggioni
,
Vivencio Barrios
,
Andrew L. Clark
,
Thibaud Damy
,
Cândida Fonseca
,
Lars H. Lund
,
Stefanie Kalus
,
C Koch
,
Uwe Zeymer
Discussion(0)
No comments yet. Be the first to comment.